CLR 131 Achieves 50% Overall Response Rate in Cohort 6 of Ongoing Phase 1 Study in Relapsed or Refractory Multiple Myeloma

World News: . []

FLORHAM PARK NJ May 15 2019 GLOBE NEWSWIRE -- LINK  Biosciences IncNASDAQ CLRB a clinical-stage biopharmaceutical company LINK  on the discovery development and commercialization of drugs for the treatment of LINK  today an nounced...

More news and information about Cellectar Biosciences

Published By:

Globe Newswire: 13:30 GMT Wednesday 15th May 2019

Published: .

Search for other references to "achieves" on SPi News


Share

Previous StoryNext Story

SPi News is published by Sector Publishing Intelligence Ltd.
© Sector Publishing Intelligence Ltd 2019. [Admin Only]
 
Sector Publishing Intelligence Ltd.
Agriculture House, Acland Road, DORCHESTER, Dorset DT1 1EF United Kingdom
Registered in England and Wales number 07519380.
 
Privacy Policy | Terms and Conditions | Contact Us